ClinicalTrials.gov
public full text
Public Domain
Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion
This is a phase I, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK and PD of HSK41959 when given orally in patients with MTAP Deletion locally advanced or metastatic Solid Tumors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion#1088043
- Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer#865536
- Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients#850964
- A Study for HSK39775 in Participants With Solid Tumors#897966
- Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma#1094180
Record · ID 907346
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive